−2.6640EUR
−173.50 MEUR
40.16 MEUR
46.54 M
About MITHRA
Sector
Headquarters
Liege
Founded
1999
Website
ISIN
BE0974283153
FIGI
BBG009CK56Q5
Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. It operates through the following segments: Product Sales, Out-Licensing, and Other. The Product Sales segment includes complex therapeutics, estetrol, and the remaining portfolio of generic products. The Out-Licensing segment offers partnership deals. The Other segment is involved in the research and development services rendered to third parties. The company was founded by Jean-Michel Foidart and Fran?ois Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MITRA is 0.2330 EUR — it has increased by 5.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange MITHRA stocks are traded under the ticker MITRA.
MITRA stock is 5.88% volatile and has beta coefficient of 0.76. Check out the list of the most volatile stocks — is MITHRA there?
One year price forecast for MITHRA has a max estimate of 2.8000 EUR and a min estimate of 0.1000 EUR.
Yes, you can track MITHRA financials in yearly and quarterly reports right on TradingView.
MITRA stock has fallen by 0.21% compared to the previous week, the month change is a 12.02% rise, over the last year MITHRA has showed a 92.18% decrease.
MITRA net income for the last quarter is −123.03 M EUR, while the quarter before that showed −50.47 M EUR of net income which accounts for −143.78% change. Track more MITHRA financial stats to get the full picture.
Today MITHRA has the market capitalization of 15.24 M, it has decreased by 8.91% over the last week.
No, MITRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MITRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MITHRA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MITHRA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MITHRA stock shows the sell signal. See more of MITHRA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MITHRA future price: according to them, MITRA price has a max estimate of 2.80 EUR and a min estimate of 0.10 EUR. Read a more detailed MITHRA forecast: see what analysts think of MITHRA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MITHRA EBITDA is −57.61 M EUR, and current EBITDA margin is −142.22%. See more stats in MITHRA financial statements.